Legal structures

A presentation by Alexandra 'Sasha' Latypova. Latypova is a former pharmaceutical industry executive and entrepreneur. The Spotlight Conference April 15th, 2023 Stavanger, Norway Event made possible b

There is evidence to date of the collusion between the manufacturers, the global regulatory agencies, and the US Department of Defense that led to the commercial release of the Covid-19 countermeasures that do not comply with the current Good Manufacturing Practices (cGMP). The video describes public data from CDC's VAERS database as well as various documents that have been obtained through FOIA releases and other sources. Evidence includes Moderna's non-clinical study summaries, Pfizer’s Chemistry Manufacturing and Controls documentation, and contracts between pharma and the DOD for supply of the mRNA/DNA products. It reveals disregard for established safety rules, regulations, and safety practices throughout the development, manufacture, and distribution of these products.

The FDA’s Emergency Use Authorization for the vaccines was based on clinical trials and manufacturing processes conducted with no binding legal standards, no legally proscribed safety oversight or regulation, and no legal redress from the manufacturer for potential harms. (This last point is being challenged in multiple court cases, so far to no avail.)

It is eminently apparent, given all the information in this article, and in the preceding Part 1, that the BioNTach/Pfizer Covid mRNA vaccines were developed, manufactured, and authorized under military laws reserved for emergency situations involving biological warfare/terrorism, not naturally occurring diseases affecting the entire civilian population.